Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil-Reference-Cited by-同舟云学术

Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil

Published:2024-08 Issue: Volume: Page:
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Esquirol Albert^ORCID,Pascual Maria Jesus,Montoro Juan,Piñana José Luis,Ferrà Christelle,Herruzo Beatriz^ORCID,Garcia-Cadenas Irene,Balaguer Aitana,Perez Ariadna,Huguet Maria,Redondo Sara^ORCID,Villalba Marta,Hernandez-Boluda Juan Carlos,Chorao Pedro^ORCID,Hernani Rafael,Sanz Jaime^ORCID,Solano Carlos^ORCID,Sierra Jorge^ORCID,Martino Rodrigo

Publisher

Elsevier BV

Reference42 articles.

1. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using post-transplantation cyclophosphamide;O'Donnell;Biol Blood Marrow Transplant,2002

2. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, post-transplantation cyclophosphamide;Luznik;Biol Blood Marrow Transplant,2008

3. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor;Bashey;Bone Marrow Transplant,2014

4. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts;Raiola;Biol Blood Marrow Transplant,2014